Early phase clinical trials of anticancer agents in children and adolescents - an ITCC perspective.
about
Development of Molecularly Targeted Therapies to Treat Pediatric Malignancies.Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology EuroPrecision medicine in pediatric oncology.Cell death-based treatment of childhood cancer.Risk and surrogate benefit for pediatric Phase I trials in oncology: A systematic review with meta-analysis.
P2860
Early phase clinical trials of anticancer agents in children and adolescents - an ITCC perspective.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Early phase clinical trials of ...... escents - an ITCC perspective.
@ast
Early phase clinical trials of ...... escents - an ITCC perspective.
@en
type
label
Early phase clinical trials of ...... escents - an ITCC perspective.
@ast
Early phase clinical trials of ...... escents - an ITCC perspective.
@en
prefLabel
Early phase clinical trials of ...... escents - an ITCC perspective.
@ast
Early phase clinical trials of ...... escents - an ITCC perspective.
@en
P2093
P2860
P50
P1476
Early phase clinical trials of ...... escents - an ITCC perspective.
@en
P2093
Andre Baruchel
Andrew D J Pearson
Birgit Geoerger
Bruce Morland
C Michel Zwaan
Gilles Vassal
Innovative Therapies for Children with Cancer (ITCC) Consortium
Irene Jimenez
Josef Vormoor
Xavier Paoletti
P2860
P304
P356
10.1038/NRCLINONC.2017.59
P407
P577
2017-05-16T00:00:00Z